Información de la publicación

Portal del Investigador > en > Publications > publication-detail

Cost and quality of life analysis associated with allogeneic hematopoietic progenitor transplantation

Other conference communications or articles related to authors from the University of Cantabria

Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development - Article
Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome - Article
Randomized phase 2 study of weekly carfilzomib 70 Mg/m2 and dexamethasone plus/minus cyclophosphamide in relapsed and/or refractory multiple myeloma (RRMM) patients (GEM-KyCyDex) - Article
Hnrnpk overexpression drives nucleolar aberrancies causing ribosomopathies - Conference object
Genetic subtyping using whole exome sequencing across large B cell lymphoma entities in a series of 109 DLBCL and plasmablastic lymphoma cases - Conference object
Results from the cohort-expansion stage of a phase I trial of tinostamustine monotherapy in advanced Hodgkin Lymphoma (HL), Non-Hodgkin Lymphoma (NHL) and multiple myeloma (MM) (NCT02576496) - Conference object
30-minute infusion of isatuximab in newly diagnosed multiple myeloma (NDMM) patients: results of a phase 1b study - Conference object
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients - Article
The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis - Article
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma - Article
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile - Article
Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma - Article
ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor - Article
Comparative effectiveness of linvoseltamab versus current real-world (RW) standard-of-care (SOC) therapies in triple-class exposed relapsed/refractory multiple myeloma (RRMM): key subgroups analysis - Conference object
A first in human study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-hodgkin lymphoma, acute myeloid leukemia, or multiple myeloma - Conference object
Isatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) in patients with newly diagnosed multiple myeloma (NDMM) not eligible or with no immediate intent for transplant: long-term efficacy and safety in a phase 1b study - Conference object
Mezigdomide (MEZI) in novel-novel combinations for relapsed or refractory multiple myeloma (RRMM): preliminary results from the CA057-003 trial - Conference object
Zanubrutinib is effective in the treatment of patients with Waldenström's Macroglobulinemia and Bing-Neel Syndrome: a retrospective multicenter study - Conference object
Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment - Article
Murine AGM single-cell profiling identifies a continuum of hemogenic endothelium differentiation marked by ACE - Article
Identification of novel regulators of developmental hematopoiesis using Endoglin regulatory elements as molecular probes - Article
Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies - Article
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial - Article
Thromboticmicroangiopathies/Thrombocytopenias: clinical and epidemiological - Conference object
Reevaluating the IMWG multiple myeloma complete response criterion in the era of mass spectrometry: a critical analysis - Conference object
Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations - Article
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia - Article
Natural history and cell of origin of TC F3- ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL - Article
Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs - Article
PLCG1 mutations in cutaneous T-cell lymphomas - Article

Congress: ASH Annual Meeting and Exposition (67º : 2025 : Orlando, Florida)

Publisher: American Society of Hematology

Year of publication: 2025

No. of pages: 2

Publication type: Conference object

DOI: 10.1182/blood-2025-2480

ISSN: 0006-4971,1528-0020

Publication Url: https://doi.org/10.1182/blood-2025-2480

Read publication

Authorship

FERNÁNDEZ-LUIS, SARA

PALOMA LANZA LEON

MARINA BARREDA GUTIERREZ

OCHAGAVÍA, MARÍA

ILLARO, AITZIBER

PAJARES, ALBERTO

VEGA, LEDDY

BERMÚDEZ, ARANCHA

FERNÁNDEZ, PATRICIA

ÁLVAREZ, NOEMÍ

ESPAÑA, LUCÍA

PICÓN, PAULA

DAVID CANTARERO PRIETO

LUCRECIA YAÑEZ SAN SEGUNDO

Download reference

Bib Ris

Back

Researchers portal

Portal del personal investigador

Cost and quality of life analysis associated with allogeneic hematopoietic progenitor transplantation

Authorship

Download reference